Medications purchased at discounted rates under the federal 340B program hit a record $24.3 billion in 2018, up 26 percent from 2017, according to Health Resources and Service Administration data cited by pharmaceutical website Drug Channels.
Pharmacy
A San Francisco jury ordered Bayer to pay more than $2 billion to a couple who claimed the company's weedkiller caused their cancer, according to CNBC.
The $300 billion of Chinese imports potentially subject to U.S. tariffs won't include pharmaceuticals and select medical products, according to Reuters.
An assistant pharmacy professor at the University of Rhode Island in South Kingstown resigned after she was convicted of defrauding government regulators by dispensing drugs without valid prescriptions, according to The Providence Journal.
Purdue Pharma has removed the signs bearing its name and logo at its downtown headquarters in Stamford, Conn., according to the Stamford Advocate.
Advertisement
New Jersey has eased some provisions in a rule that sought to restrict gifts and payments that drugmakers can give to physicians, according to STAT.
The FDA has finalized its long-awaited guidance on when biosimilars can be considered interchangeable with biologics.
Specialty drugmaker Insys said Monday that it may be forced to file for Chapter 11 bankruptcy because it can't afford the legal costs related to a U.S. Justice Department probe, and its shares plummeted on the news, according to CNBC.
Novartis and Teva Pharmaceuticals, two of the defendants named in a wide-reaching lawsuit against generic drugmakers, have vowed to fight the allegations of price-fixing brought against them, according to a BioSpace news report.
In an unusual move, Novartis began offering price discounts in negotiations with insurers for its pricey gene therapy for spinal muscular atrophy — but there's a catch, according to Reuters.